MYDA Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.25M Buy
+6,800
New +$6.89M 1.03% 25
2025
Q4
Sell
-3,000
Closed -$2.29M 178
2025
Q3
$2.29M Buy
+3,000
New +$2.23M 0.49% 61
2023
Q3
Sell
-14,000
Closed -$6.57M 136
2023
Q2
$6.57M Buy
+14,000
New +$5.87M 1.97% 16
2019
Q1
Sell
-12,000
Closed -$1.39M 127
2018
Q4
$1.39M Buy
+12,000
New +$1.34M 2.39% 13

Other funds holding LLY

MYDA Advisors's LLY Position: Q1 2026 in Review

MYDA Advisors opened a new position in Eli Lilly (LLY) in Q1 2026: 6,800 shares worth $6.25M. The stake represents 1.03% of the portfolio and ranks #25 among its holdings. This is a return to the name: MYDA Advisors previously reported a position in LLY as recently as Q3 2025.

MYDA Advisors first reported a position in LLY in Q4 2018 and has held it in 4 quarters since. The position peaked at $6.57M in Q2 2023. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • MYDA Advisors held 6,800 shares of Eli Lilly worth $6.25M as of Q1 2026.
  • Eli Lilly was a new MYDA Advisors position in Q1 2026.
  • Eli Lilly made up 1.03% of MYDA Advisors's portfolio in Q1 2026, its #25 holding.
  • MYDA Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 4 quarters since.
  • MYDA Advisors's Eli Lilly position peaked at $6.57M in Q2 2023.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on MYDA Advisors's 13F filing for Q1 2026, filed 14 May 2026.